Non-dipping status in arterial hypertension: An overview

Current Vascular Pharmacology

Volumn 12, Issue 3, 2014, Pages 527-536

  Sarigianni, Maria ^a   Dimitrakopoulos, Konstantinos ^a   Tsapas, Apostolos ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ambulatory blood pressure monitoring; Arterial hypertension; Blood pressure; Cardiovascular risk factor; Chronotherapy; Night time blood pressure; Non dipping

Indexed keywords

MYOCARDIN; TRANSCRIPTION FACTOR GATA 4; ANTIHYPERTENSIVE AGENT;

ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; AUTONOMIC NEUROPATHY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CHRONOTHERAPY; CIRCADIAN RHYTHM; GENE EXPRESSION; HUMAN; HYPERTENSION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; KIDNEY CYST; NON DIPPING ARTERIAL HYPERTENSION; OVARY POLYCYSTIC DISEASE; PITTSBURGH SLEEP QUALITY INDEX; PREVALENCE; PULSE WAVE; RENOVASCULAR DISEASE; SLEEP DISORDERED BREATHING; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPLICATION; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; RISK;

EID: 84922392169     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016111203140518173019     Document Type: Article

References (126)

1. [1] http: //www.nice.org.uk/guidance/CG127.
2. [2] Mayor S. Hypertension diagnosis should be based on ambulatory blood pressure monitoring, NICE recommends. BMJ 2011; 343: d5421.
3. [3] Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
4. [4] O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988; 2: 397.
5. [5] Hansen TW, Li Y, Boggia J, et al. Predictive role of the nighttime blood pressure. Hypertension 2011; 57: 3-10.
6. [6] Routledge FS, McFetridge-Durdle JA, Dean CR. Night-time blood pressure patterns and target organ damage: a review. Can J Cardiol 2007; 23: 132-8.
7. [7] Birkenhager AM, van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med 2007; 65: 127-31.
8. [8] Bastos JM, Bertoquini S, Polonia J. Prognostic value of subdivisions of nighttime blood pressure fall in hypertensives followed up for 8.2 years. Does nondipping classification need to be redefined? J Clin Hypertens (Greenwich) 2010; 12: 508-15.
9. [9] Cavelaars M, Tulen JH, van Bemmel JH, et al. Physical activity, dipping and haemodynamics. J Hypertens 2004; 22: 2303-9.
10. [10] Henskens LH, Kroon AA, van Oostenbrugge RJ, et al. Different classifications of nocturnal blood pressure dipping affect the prevalence of dippers and nondippers and the relation with targetorgan damage. J Hypertens 2008; 26: 691-8.
11. [11] Syrseloudis D, Tsioufis C, Aragiannis D, et al. The dominant role of the systolic component of nondipping status on target-organ damage in never-treated hypertensives. Am J Hypertens 2011; 24: 292-8.
12. [12] Cuspidi C, Meani S, Valerio C, et al. Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age. Blood Press Monit 2007; 12: 101-6.
13. [13] James MA, Fotherby MD, Potter JF. Reproducibility of the circadian systolic blood pressure variation in the elderly. J Hypertens 1995; 13: 1097-103.
14. [14] Manning G, Rushton L, Donnelly R, et al. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens 2000; 13: 1035-8.
15. [15] Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998; 16: 733-8.
16. [16] Lurbe E, Redon J, Pascual JM, et al. The spectrum of circadian blood pressure changes in type I diabetic patients. J Hypertens 2001; 19: 1421-8.
17. [17] Cuspidi C, Meani S, Lonati L, et al. Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J Hypertens 2006; 24: 647-53.
18. [18] Mansoor GA. Sleep actigraphy in hypertensive patients with the 'non-dipper' blood pressure profile. J Hum Hypertens 2002; 16: 237-42.
19. [19] Yamasaki F, Schwartz JE, Gerber LM, et al. Impact of shift work and race/ethnicity on the diurnal rhythm of blood pressure and catecholamines. Hypertension 1998; 32: 417-23.
20. [20] McGowan NJ, Gough K, Padfield PL. Nocturnal dipping is reproducible in the long term. Blood Press Monit 2009; 14: 185-9.
21. [21] O'Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23: 697-701.
22. [22] McGowan N, Atkins N, O'Brien E, et al. Computerized reporting improves the clinical use of ambulatory blood pressure measurement. Blood Press Monit 2010; 15: 115-23.
23. [23] McGowan N, Gough K, Maxwell S, et al. How do we use ambulatory measurement of blood pressure in the management of hypertension? Blood Press Monit 2007; 12: 385-6.
24. [24] Kanbay M, Turgut F, Uyar ME, et al. Causes and mechanisms of nondipping hypertension. Clin Exp Hypertens 2008; 30: 585-97.
25. [25] Myredal A, Friberg P, Johansson M. Elevated myocardial repolarization lability and arterial baroreflex dysfunction in healthy individuals with nondipping blood pressure pattern. Am J Hypertens 2010; 23: 255-9.
26. [26] Okamoto LE, Gamboa A, Shibao C, et al. Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension 2009; 53: 363-9.
27. [27] Grassi G, Seravalle G, Quarti-Trevano F, et al. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension 2008; 52: 925-31.
28. [28] Nagai M, Hoshide S, Ishikawa J, et al. Insular cortex atrophy as an independent determinant of disrupted diurnal rhythm of ambulatory blood pressure in elderly hypertension. Am J Hypertens 2009; 22: 723-9.
29. [29] Zhang Y, Agnoletti D, Blacher J, et al. Blood pressure variability in relation to autonomic nervous system dysregulation: the X-CELLENT study. Hypertens Res 2011; 35: 399-403.
30. [30] Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 2006; 48: 527-33.
31. [31] Uzu T, Ishikawa K, Fujii T, et al. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 96: 1859-62.
32. [32] Kimura G, Brenner BM. Implications of the linear pressure natriuresis relationship and importance of sodium sensitivity in hypertension. J Hypertens 1997; 15: 1055-61.
33. [33] Fukuda M, Mizuno M, Yamanaka T, et al. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 2008; 52: 1155-60.
34. [34] Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res 2010; 33: 515-20.
35. [35] Al-Said J, Brumback MA, Moghazi S, et al. Reduced renal function in patients with simple renal cysts. Kidney Int 2004; 65: 2303-8.
36. [36] Chin HJ, Ro H, Lee HJ, et al. The clinical significances of simple renal cyst: Is it related to hypertension or renal dysfunction? Kidney Int 2006; 70: 1468-73.
37. [37] Pedersen JF, Emamian SA, Nielsen MB. Significant association between simple renal cysts and arterial blood pressure. Br J Urol 1997; 79: 688-91.
38. [38] Luscher TF, Wanner C, Siegenthaler W, et al. Simple renal cyst and hypertension: cause or coincidence? Clin Nephrol 1986; 26: 91-5.
39. [39] Preisig PA, Franch HA. Renal epithelial cell hyperplasia and hypertrophy. Semin Nephrol 1995; 15: 327-40.
40. [40] Afsar B, Afsar RE, Sen ST, et al. Simple renal cysts and circadian blood pressure: are they related to each other in patients with hypertension? Int Urol Nephrol 2010; 43: 157-165.
41. [41] Anusionwu OF. Non-dipping phenomenon in patients with essential hypertension with renal cysts. Int Urol Nephrol 2011; 43: 245.
42. [42] Kario K. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure. Hypertens Res 2009; 32: 428-32.
43. [43] Wolf J, Hering D, Narkiewicz K. Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res 2010; 33: 867-71.
44. [44] Lloberes P, Lozano L, Sampol G, et al. Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension. J Sleep Res 2010; 19: 597-602.
45. [45] Matthews KA, Kamarck TW, Hau M, et al. Blood pressure dipping and sleep disturbance in African-American and Caucasian men and women. Am J Hypertens 2008; 21: 826-31.
46. [46] Knutson KL, Spiegel K, Penev P, et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11: 163-78.
47. [47] Huang Y, Mai W, Hu Y, et al. Poor sleep quality, stress status, and sympathetic nervous system activation in nondipping hypertension. Blood Press Monit 2011; 16: 117-23.
48. [48] Erden I, Erden EC, Ozhan H, et al. Poor-quality sleep score is an independent predictor of nondipping hypertension. Blood Press Monit 2010; 15: 184-7.
49. [49] Routledge FS, McFetridge-Durdle JA, Dean CR. Stress, menopausal status and nocturnal blood pressure dipping patterns among hypertensive women. Can J Cardiol 2009; 25: e157-63.
50. [50] Kontaraki JE, Marketou ME, Zacharis EA, et al. Early cardiac gene transcript levels in peripheral blood mononuclear cells in patients with untreated essential hypertension. J Hypertens 2011; 29: 791-7.
51. [51] de la Sierra A, Segura J, Gorostidi M, et al. Diurnal blood pressure variation, risk categories and antihypertensive treatment. Hypertens Res 2010; 33: 767-71.
52. [52] Kotsis V, Stabouli S, Bouldin M, et al. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005; 45: 602-7.
53. [53] Vasunta RL, Kesaniemi YA, Ylitalo A, et al. Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study. Am J Hypertens 2012; 25: 60-6.
54. [54] Hermida RC, Chayan L, Ayala DE, et al. Association of metabolic syndrome and blood pressure nondipping profile in untreated hypertension. Am J Hypertens 2009; 22: 307-13.
55. [55] Vyssoulis GP, Karpanou EA, Kyvelou SM, et al. Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients. Blood Press Monit 2007; 12: 351-6.
56. [56] Cuspidi C, Meani S, Valerio C, et al. Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension. Blood Press Monit 2005; 10: 175-80.
57. [57] Athyros VG, Ganotakis ES, Tziomalos K, et al. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin 2010; 26: 713-9.
58. [58] Hermida RC, Chayan L, Ayala DE, et al. Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension. Chronobiol Int 2011; 28: 509-19.
59. [59] Ukkola O, Vasunta RL, Kesaniemi YA. Non-dipping pattern in ambulatory blood pressure monitoring is associated with metabolic abnormalities in a random sample of middle-aged subjects. Hypertens Res 2009; 32: 1022-7.
60. [60] Athyros VG, Ganotakis E, Kolovou GD, et al. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr Vasc Pharmacol 2011; 9: 647-57.
61. [61] Gorostidi M, de la Sierra A, Gonzalez-Albarran O, et al. Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes. Hypertens Res 2011; 34: 1185-9.
62. [62] Jennersjo PE, Wijkman M, Wirehn AB, et al. Circadian blood pressure variation in patients with type 2 diabetes--relationship to macro-and microvascular subclinical organ damage. Prim Care Diabetes 2011; 5: 167-73.
63. [63] Sturrock ND, George E, Pound N, et al. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med 2000; 17: 360-4.
64. [64] Izzo JL Jr. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol 2004; 19: 341-52.
65. [65] Cavalcante JL, Lima JA, Redheuil A, et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011; 57: 1511-22.
66. [66] Koumaras C, Tzimou M, Stavrinou E, et al. Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics. Am J Cardiovasc Drugs 2012; 12: 143-56.
67. [67] Li Y, Wang JG, Dolan E, et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 2006; 47: 359-64.
68. [68] Muxfeldt ES, Fiszman R, Castelpoggi CH, et al. Ambulatory arterial stiffness index or pulse pressure: which correlates better with arterial stiffness in resistant hypertension? Hypertens Res 2008; 31: 607-13.
69. [69] Gavish B, Ben-Dov IZ, Kark JD, et al. The association of a simple blood pressure-independent parameter derived from ambulatory blood pressure variability with short-term mortality. Hypertens Res 2009; 32: 488-95.
70. [70] Lee HT, Lim YH, Kim BK, et al. The relationship between ambulatory arterial stiffness index and blood pressure variability in hypertensive patients. Korean Circ J 2011; 41: 235-40.
71. [71] Parati G, Schillaci G. What are the real determinants of the ambulatory arterial stiffness index? J Hypertens 2012; 30: 472-6.
72. [72] Schillaci G, Parati G, Pirro M, et al. Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension 2007; 49: 986-91.
73. [73] Baumann M, Dan L, Nurnberger J, et al. Association of ambulatory arterial stiffness index and brachial pulse pressure is restricted to dippers. J Hypertens 2008; 26: 210-4.
74. [74] Castelpoggi CH, Pereira VS, Fiszman R, et al. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension. Hypertens Res 2009; 32: 591-6.
75. [75] Jerrard-Dunne P, Mahmud A, Feely J. Circadian blood pressure variation: relationship between dipper status and measures of arterial stiffness. J Hypertens 2007; 25: 1233-9.
76. [76] Syrseloudis D, Tsioufis C, Andrikou I, et al. Association of nighttime hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertens Res 2011; 34: 120-5.
77. [77] Higashi Y, Nakagawa K, Kimura M, et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol 2002; 40: 2039-43.
78. [78] Meldrum DR, Gambone JC, Morris MA, et al. The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol 2011; 108: 599-606.
79. [79] Shabbir M, Mikhailidis DM, Morgan RJ. Erectile dysfunction: an underdiagnosed condition associated with multiple risk factors. Curr Med Res Opin 2004; 20: 603-6.
80. [80] Doumas M, Tsakiris A, Douma S, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl 2006; 27: 469-77.
81. [81] Erden I, Ozhan H, Ordu S, et al. The effect of non-dipper pattern of hypertension on erectile dysfunction. Blood Press 2010; 19: 249-53.
82. [82] Inanc T, Kaya MG, Yarlioglues M, et al. The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives. Blood Press 2010; 19: 81-5.
83. [83] Ordu S, Ozhan H, Caglar O, et al. Mean platelet volume in patients with dipper and non-dipper hypertension. Blood Press 2010; 19: 26-30.
84. [84] Kaya MG, Yarlioglues M, Gunebakmaz O, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209: 278-82.
85. [85] Brown AS, Hong Y, de Belder A, et al. Mega karyocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 802-7.
86. [86] Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011; 17: 47-58.
87. [87] Kargili A, Karakurt F, Kasapoglu B, et al. Association of polycystic ovary syndrome and a non-dipping blood pressure pattern in young women. Clinics (Sao Paulo) 2010; 65: 475-9.
88. [88] Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010; 95: 2038-49.
89. [89] Vyssoulis G, Karpanou E, Tzamou V, et al. Serum phosphate in white-coat hypertensive patients: focus on dipping status and metabolic syndrome. Hypertens Res 2010; 33: 825-30.
90. [90] Feldstein CA, Akopian M, Pietrobelli D, et al. Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism. Clin Exp Hypertens 2010; 32: 154-8.
91. [91] Afsar B, Elsurer R, Sezer S, et al. Nondipping phenomenon and quality of life: are they related in essential hypertensive patients? Clin Exp Hypertens 2010; 32: 105-12.
92. [92] Scuteri A, Spalletta G, Cangelosi M, et al. Decreased nocturnal systolic blood pressure fall in older subjects with depression. Aging Clin Exp Res 2009; 21: 292-7.
93. [93] Yano Y, Inokuchi T, Hoshide S, et al. Association of poor physical function and cognitive dysfunction with high nocturnal blood pressure level in treated elderly hypertensive patients. Am J Hypertens 2011; 24: 285-91.
94. [94] Rosano C, Kuller LH, Chung H, et al. Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. J Am Geriatr Soc 2005; 53: 649-54.
95. [95] Hermida RC, Calvo C, Ayala DE, et al. Relationship between physical activity and blood pressure in dipper and non-dipper hypertensive patients. J Hypertens 2002; 20: 1097-104.
96. [96] Gluba A, Bielecka A, Mikhailidis DP, et al. An update on biomarkers of heart failure in hypertensive patients. J Hypertens 2012.
97. [97] Cuspidi C, Meani S, Valerio C, et al. Nocturnal non-dipping pattern in untreated hypertensives at different cardiovascular risk according to the 2003 ESH/ESC guidelines. Blood Press 2006; 15: 37-44.
98. [98] Viera AJ, Zhu S, Hinderliter AL, et al. Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults: the CARDIA study. J Am Soc Hyper tens 2011; 5: 48-55.
99. [99] Kabutoya T, Hoshide S, Ishikawa J, et al. The effect of pulse rate and blood pressure dipping status on the risk of stroke and cardiovascular disease in Japanese hypertensive patients. Am J Hypertens 2010; 23: 749-55.
100. [100] Fagard RH, Celis H, Thijs L, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51: 55-61.
101. [101] Berrut G, Bouhanick B, Fabbri P, et al. Loss of the nocturnal decline in blood pressure in subjects with essential hypertension and microalbuminuria. Blood Press Monit 1996; 1: 469-473.
102. [102] Afsar B, Elsurer R. Urinary albumin excretion among nondipper hypertensive patients is closely related with the pattern of nondipping. J Am Soc Hyper tens 2010; 4: 196-202.
103. [103] Kastarinen H, Vasunta RL, Ukkola O, et al. Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring--a cross-sectional population-based study. J Hum Hyper tens 2010; 24: 247-53.
104. [104] Muxfeldt ES, Salles GF. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension? J Hypertens 2008; 26: 878-84.
105. [105] Timio M, Venanzi S, Lolli S, et al. "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995; 43: 382-7.
106. [106] Hermida RC, Ayala DE, Mojon A, et al. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int 2010; 27: 1629-51.
107. [107] Hermida RC, Calvo C, Ayala DE, et al. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension 2005; 46: 960-8.
108. [108] Portaluppi F, Smolensky MH. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol Int 2010; 27: 1652-67.
109. [109] Almirall J, Comas L, Martinez-Ocana JC, et al. Effects of chronotherapy on blood pressure control in non-dipper patients with refractory hypertension. Nephrol Dial Transplant 2012; 27: 1855-9.
110. [110] Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004; 164: 722-32.
111. [111] Portaluppi F, Vergnani L, Manfredini R, et al. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens 1995; 8: 719-26.
112. [112] Calvo C, Hermida RC, Ayala DE, et al. Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration. Med Clin (Barc) 2006; 127: 721-9.
113. 113] Zeng J, Jia M, Ran H, et al. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing-a multicenter, open-label randomized study. Hypertens Res 2011; 34: 767-72.
114. [114] Hermida RC, Ayala DE, Fernandez JR, et al. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens 2011; 24: 383-91.
115. [115] Hermida RC, Ayala DE, Fontao MJ, et al. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int 2010; 27: 560-74.
116. [116] Hermida RC, Ayala DE, Fontao MJ, et al. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int 2010; 27: 1287-303.
117. [117] Kario K. Proposal of RAS-diuretic vs. RAS-calcium antagonist strategies in high-risk hypertension: insight from the 24-hour ambulatory blood pressure profile and central pressure. J Am Soc Hypertens 2010; 4: 215-8.
118. [118] Neumann CL, Menne J, Rieken EM, et al. Blood pressure telemonitoring is useful to achieve blood pressure control in inadequately treated patients with arterial hypertension. J Hum Hypertens 2011; 25: 732-738.
119. [119] Karagiannis A, Hatzitolios AI, Athyros VG, et al. Implementation of guidelines for the management of arterial hypertension. The impulsion study. Open Cardiovasc Med J 2009; 3: 26-34.
120. [120] Stepien M, Banach M, Mikhailidis DP, et al. Role and significance of statins in the treatment of hypertensive patients. Curr Med Res Opin 2009; 25: 1995-2005.
121. [121] Karagiannis A, Tziomalos K, Anagnostis P, et al. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr Vasc Pharmacol 2010; 8: 792-803.
122. [122] Banach M, Michalska M, Kjeldsen SE, et al. What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist? Expert Opin Pharmacother 2011; 12: 1835-44.
123. [123] Wang HL, Wang Y, Zhang Y, et al. Changes in plasma angiotensin II and circadian rhythm of blood pressure in hypertensive patients with sleep apnea syndrome before and after treatment. Chin Med Sci J 2011; 26: 9-13.
124. [124] Lozano L, Tovar JL, Sampol G, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 2010; 28: 2161-8.
125. [125] Devaraj S, Siegel D, Jialal I. Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep 2011; 13: 31-42.
126. [126] Terzoli L, Mircoli L, Raco R, et al. Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors. J Cardiovasc Pharmacol 2005; 46: 310-5.